In last trading session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) saw 0.3 million shares changing hands with its beta currently measuring 1.74. Company’s recent per share price level of $0.30 trading at $0.01 or 3.17% at ring of the bell on the day assigns it a market valuation of $1.54M. That closing price of QNRX’s stock is at a discount of -423.33% from its 52-week high price of $1.57 and is indicating a premium of 10.0% from its 52-week low price of $0.27. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.72 million shares which gives us an average trading volume of 5.87 million if we extend that period to 3-months.

For Quoin Pharmaceuticals Ltd ADR (QNRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.42 in the current quarter.

Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information

Upright in the green during last session for gaining 3.17%, in the last five days QNRX remained trading in the red while hitting it’s week-highest on Thursday, 03/13/25 when the stock touched $0.30 price level, adding 5.57% to its value on the day. Quoin Pharmaceuticals Ltd ADR’s shares saw a change of -53.22% in year-to-date performance and have moved -1.75% in past 5-day. Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) showed a performance of -4.59% in past 30-days. Number of shares sold short was 2.68 million shares which calculate 0.26 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -194.79% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 13.35% while estimates for its earnings growth in next 5 years are of 66.78%.

Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders

Insiders are in possession of 16.57% of company’s total shares while institution are holding 18.89 percent of that, with stock having share float percentage of 22.64%. Investors also watch the number of corporate investors in a company very closely, which is 18.89% institutions for Quoin Pharmaceuticals Ltd ADR that are currently holding shares of the company.